Sign in
4

Changes in Ownership

Enliven Therapeutics, Inc. Filed Acc 0001415889-24-004012

Options or other derivatives

  • CHIEF MEDICAL OFFICER acquired 185,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Collins Helen Louise CHIEF MEDICAL OFFICER 2024-02-13 Grant or award · Stock Option (right to buy) +185,000 185,000 D
Loading xslF345X05/form4-02162024_010221.xml…